{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["1,25-dihydroxyvitamin D", "COVID-19", "bioinformatics", "diabetes mellitus", "molecular docking", "network pharmacology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36532549", "DateRevised": {"Year": "2022", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "02"}], "Language": ["eng"], "ELocationID": ["1060095", "10.3389/fnut.2022.1060095"], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "Integrated bioinformatics and <i>in silico</i> approaches reveal the biological targets and molecular mechanisms of 1,25-dihydroxyvitamin D against COVID-19 and diabetes mellitus.", "Pagination": {"StartPage": "1060095", "MedlinePgn": "1060095"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) and diabetes mellitus (DM) are two major diseases threatening human health. The susceptibility of DM patients to COVID-19 and their worse outcomes have forced us to explore efficient routes to combat COVID-19/DM. As the most active form of Vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D) has been shown a beneficial effect in the treatment of COVID-19/DM. However, the anti-COVID-19/DM mechanisms of 1,25(OH)<sub>2</sub>D remain unclear. In this study, an approach combining network pharmacology and molecular docking was performed to reveal the potential hub target genes and underlying mechanisms of 1,25(OH)<sub>2</sub>D in the treatment of COVID-19/DM. The hub targets and interaction pathways related to 1,25(OH)<sub>2</sub>D were identified by integrating the key 1,25(OH)<sub>2</sub>D-target-signaling pathway-COVID-19/DM networks. Fifteen hub targets of 1,25(OH)<sub>2</sub>D against COVID-19DM were determined, including EGFR, PIK3R1, PIK3CA, STAT3, MAPK1, ESR1, HSP90AA1, LCK, MTOR, IGF1, AR, NFKB1, PIK3CB, PTPN1, and MAPK14. An enrichment analysis of the hub targets further revealed that the effect of 1,25(OH)<sub>2</sub>D against COVID-19/DM involved multiple biological processes, cellular components, molecular functions and biological signaling pathways. Molecular docking disclosed that 1,25(OH)<sub>2</sub>D docked nicely with the hub target proteins, including EGFR, PIK3R1, and PIK3CA. These findings suggested that the potential mechanisms of 1,25(OH)<sub>2</sub>D against COVID-19/DM may be related to multiple biological targets and biological signaling pathways."], "CopyrightInformation": "Copyright \u00a9 2022 Zeng, Xu, Tang, Yan and Wei."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, China."}], "LastName": "Zeng", "ForeName": "Fanqiang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Botanical Garden of Medicinal Plants, Nanning, China."}], "LastName": "Xu", "ForeName": "Yongli", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Hainan Medical University, Haikou, China."}], "LastName": "Tang", "ForeName": "Chaoling", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Botanical Garden of Medicinal Plants, Nanning, China."}], "LastName": "Yan", "ForeName": "Zhigang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, China."}], "LastName": "Wei", "ForeName": "Chaohe", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "K\u00e4sk L, Larsen TH, Schj\u00f8tt J, Saeed S. The possibility of hypersensitivity myocarditis following COVID-19 vaccines: implications for contrast echocardiography. Cardiology. (2022) 147:417\u20138. 10.1159/000525349", "ArticleIdList": ["10.1159/000525349", "35662180"]}, {"Citation": "Kounis NG, Mplani V, Koniari I, Velissaris D. Hypersensitivity myocarditis and COVID-19 vaccines. Kardiol Pol. (2022) 80:109\u201310. 10.33963/KP.a2021.0166", "ArticleIdList": ["10.33963/KP.a2021.0166", "34856634"]}, {"Citation": "Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, et al. . Bell's palsy following vaccination with mRNA (BNT162B2) and inactivated (Coronavac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. (2022) 22:64\u201372. 10.1016/S1473-3099(21)00451-5", "ArticleIdList": ["10.1016/S1473-3099(21)00451-5", "PMC8367195", "34411532"]}, {"Citation": "National Institute for Health and Care Excellence: Guidelines . COVID-19 Rapid Guideline: Vaccine-Induced Immune Thrombocytopenia and Thrombosis (Vitt). London: National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2021. (2022)."}, {"Citation": "Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, et al. . Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol. (2020) 183:R133\u2013r47. 10.1530/EJE-20-0665", "ArticleIdList": ["10.1530/EJE-20-0665", "PMC9494342", "32755992"]}, {"Citation": "Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. (2014) 2:56\u201364. 10.1016/S2213-8587(13)70112-8", "ArticleIdList": ["10.1016/S2213-8587(13)70112-8", "24622669"]}, {"Citation": "Idf Diabetes Atlas. Brussels: International Diabetes Federation \u00a9 International Diabetes Federation (2021)."}, {"Citation": "Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. (2020) 318:E736\u2013e41. 10.1152/ajpendo.00124.2020", "ArticleIdList": ["10.1152/ajpendo.00124.2020", "PMC7191633", "32228322"]}, {"Citation": "Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. (2020) 146:110\u20138. 10.1016/j.jaci.2020.04.006", "ArticleIdList": ["10.1016/j.jaci.2020.04.006", "PMC7152876", "32294485"]}, {"Citation": "Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054\u201362. 10.1016/S0140-6736(20)30566-3", "ArticleIdList": ["10.1016/S0140-6736(20)30566-3", "PMC7270627", "32171076"]}, {"Citation": "Singh AK, Khunti K. COVID-19 and diabetes. Annu Rev Med. (2022) 73:129\u201347. 10.1146/annurev-med-042220-011857", "ArticleIdList": ["10.1146/annurev-med-042220-011857", "34379444"]}, {"Citation": "Park JE, Pichiah PBT, Cha YS. Vitamin D and metabolic diseases: growing roles of vitamin D. J Obesity Metab Syndr. (2018) 27:223\u201332. 10.7570/jomes.2018.27.4.223", "ArticleIdList": ["10.7570/jomes.2018.27.4.223", "PMC6513299", "31089567"]}, {"Citation": "Lemieux P, Weisnagel SJ, Caron AZ, Julien AS, Morisset AS, Carreau AM, et al. . Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Eur J Endocrinol. (2019) 181:287\u201399. 10.1530/EJE-19-0156", "ArticleIdList": ["10.1530/EJE-19-0156", "31344685"]}, {"Citation": "Zhang Y, Tan H, Tang J, Li J, Chong W, Hai Y, et al. . Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care. (2020) 43:1650\u20138. 10.2337/dc19-1708", "ArticleIdList": ["10.2337/dc19-1708", "33534730"]}, {"Citation": "Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G, et al. . High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (Covit-Trial): a multicenter, open-label, randomized controlled superiority trial. PLoS Med. (2022) 19:e1003999. 10.1371/journal.pmed.1003999", "ArticleIdList": ["10.1371/journal.pmed.1003999", "PMC9154122", "35639792"]}, {"Citation": "Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity: vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord. (2022) 23:579\u201399. 10.1007/s11154-021-09705-6", "ArticleIdList": ["10.1007/s11154-021-09705-6", "PMC8724612", "34982377"]}, {"Citation": "Kaya MO, Pamuk\u00e7u E, Yakar B. The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies. Epidemiol Health. (2021) 43:e2021074. 10.4178/epih.e2021074", "ArticleIdList": ["10.4178/epih.e2021074", "PMC8769802", "34607398"]}, {"Citation": "Ahmed AS, Alotaibi WS, Aldubayan MA, Alhowail AH, Al-Najjar AH, Chigurupati S, et al. . Factors affecting the incidence, progression, and severity of COVID-19 in type 1 diabetes mellitus. Biomed Res Int. (2021) 2021:1676914. 10.1155/2021/1676914", "ArticleIdList": ["10.1155/2021/1676914", "PMC8611355", "34840966"]}, {"Citation": "Singh SK, Jain R, Singh S. Vitamin D deficiency in patients with diabetes and COVID-19 infection. Diabetes Metab Syndr. (2020) 14:1033\u20135. 10.1016/j.dsx.2020.06.071", "ArticleIdList": ["10.1016/j.dsx.2020.06.071", "PMC7332933", "32640414"]}, {"Citation": "Leung PS. The potential protective action of vitamin D in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients. (2016) 8:147. 10.3390/nu8030147", "ArticleIdList": ["10.3390/nu8030147", "PMC4808876", "26959059"]}, {"Citation": "Pramono A, Jocken JWE, Blaak EE. Vitamin D deficiency in the aetiology of obesity-related insulin resistance. Diabetes Metab Res Rev. (2019) 35:e3146. 10.1002/dmrr.3146", "ArticleIdList": ["10.1002/dmrr.3146", "30801902"]}, {"Citation": "Vondra K, Hampl R. Vitamin D and new insights into pathophysiology of type 2 diabetes. Horm Mol Biol Clin Investig. (2021) 42:203\u20138. 10.1515/hmbci-2020-0055", "ArticleIdList": ["10.1515/hmbci-2020-0055", "33655734"]}, {"Citation": "Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. (2021) 292:198235. 10.1016/j.virusres.2020.198235", "ArticleIdList": ["10.1016/j.virusres.2020.198235", "PMC7680047", "33232783"]}, {"Citation": "Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. (2020) 8:570. 10.1016/S2213-8587(20)30183-2", "ArticleIdList": ["10.1016/S2213-8587(20)30183-2", "PMC7239633", "32445630"]}, {"Citation": "Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. (2020) 12:2097. 10.3390/nu12072097", "ArticleIdList": ["10.3390/nu12072097", "PMC7400911", "32679784"]}, {"Citation": "Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, et al. . The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. (1997) 154:S57\u201373.", "ArticleIdList": ["9379138"]}, {"Citation": "Elamir YM, Amir H, Lim S, Rana YP, Lopez CG, Feliciano NV, et al. . A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone. (2022) 154:116175. 10.1016/j.bone.2021.116175", "ArticleIdList": ["10.1016/j.bone.2021.116175", "PMC8425676", "34508882"]}, {"Citation": "Oristrell J, Oliva JC, Subirana I, Casado E, Dom\u00ednguez D, Toloba A, et al. . Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease: a population-based study. Biomedicines. (2021) 9:509. 10.3390/biomedicines9050509", "ArticleIdList": ["10.3390/biomedicines9050509", "PMC8147982", "34063015"]}, {"Citation": "Mok CK, Ng YL, Ahidjo BA, Hua Lee RC, Choy Loe MW, Liu J, et al. . Calcitriol, the Active Form of Vitamin D, Is a Promising Candidate for COVID-19 Prophylaxis (2020). Available online at: https://www.researchgate.net/publication/342388949"}, {"Citation": "Brock KE, Huang WY, Fraser DR, Ke L, Tseng M, Mason RS, et al. . Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in us middle-aged Caucasian men and women: a cross-sectional analysis within the prostate, lung, colorectal and ovarian cancer screening trial. Br J Nutr. (2011) 106:339\u201344. 10.1017/S0007114511001590", "ArticleIdList": ["10.1017/S0007114511001590", "PMC3515777", "21736838"]}, {"Citation": "Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J. Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr. (2011) 20:521\u20136. 10.6133/apjcn.2011.20.4.04", "ArticleIdList": ["10.6133/apjcn.2011.20.4.04", "22094836"]}, {"Citation": "Kjalarsdottir L, Tersey SA, Vishwanath M, Chuang JC, Posner BA, Mirmira RG, et al. . 1,25-dihydroxyvitamin D enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol. (2019) 185:17\u201326. 10.1016/j.jsbmb.2018.07.004", "ArticleIdList": ["10.1016/j.jsbmb.2018.07.004", "30071248"]}, {"Citation": "Lee TW, Kao YH, Lee TI, Chang CJ, Lien GS, Chen YJ. Calcitriol modulates receptor for advanced glycation end products (rage) in diabetic hearts. Int J Cardiol. (2014) 173:236\u201341. 10.1016/j.ijcard.2014.02.041", "ArticleIdList": ["10.1016/j.ijcard.2014.02.041", "24630381"]}, {"Citation": "Tian LQ, Yu YT, Jin MD, Duan HL, Huang G, Zhang ML. Early 1,25-dihydroxyvitamin D supplementation effectively lowers the incidence of type 2 diabetes mellitus via ameliorating inflammation in Kk-a(Y) Mice. J Nutr Sci Vitaminol. (2021) 67:84\u201390. 10.3177/jnsv.67.84", "ArticleIdList": ["10.3177/jnsv.67.84", "33952739"]}, {"Citation": "Li R, Li Y, Liang X, Yang L, Su M, Lai KP. Network pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets. Brief Bioinform. (2021) 22:1279\u201390. 10.1093/bib/bbaa300", "ArticleIdList": ["10.1093/bib/bbaa300", "PMC7717147", "33169132"]}, {"Citation": "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. . Drugbank 5.0: a major update to the drugbank database for 2018. Nucleic Acids Res. (2018) 46:D1074\u201382. 10.1093/nar/gkx1037", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Daina A, Michielin O, Zoete V. Swisstargetprediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. (2019) 47:W357\u201364. 10.1093/nar/gkz382", "ArticleIdList": ["10.1093/nar/gkz382", "PMC6602486", "31106366"]}, {"Citation": "Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. . Pharmmapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. (2017) 45:W356\u201360. 10.1093/nar/gkx374", "ArticleIdList": ["10.1093/nar/gkx374", "PMC5793840", "28472422"]}, {"Citation": "Nickel J, Gohlke BO, Erehman J, Banerjee P, Rong WW, Goede A, et al. . Superpred: update on drug classification and target prediction. Nucleic Acids Res. (2014) 42:W26\u201331. 10.1093/nar/gku477", "ArticleIdList": ["10.1093/nar/gku477", "PMC4086135", "24878925"]}, {"Citation": "Yao ZJ, Dong J, Che YJ, Zhu MF, Wen M, Wang NN, et al. . Targetnet: a web service for predicting potential drug-target interaction profiling via multi-target sar models. J Comput Aided Mol Des. (2016) 30:413\u201324. 10.1007/s10822-016-9915-2", "ArticleIdList": ["10.1007/s10822-016-9915-2", "27167132"]}, {"Citation": "Uniprot: the universal protein knowledgebase in 2021. Nucleic Acids Res. (2021) 49:D480\u20139. 10.1093/nar/gkaa1100", "ArticleIdList": ["10.1093/nar/gkaa1100", "PMC7778908", "33237286"]}, {"Citation": "Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. . The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protocols Bioinform. (2016) 54:1.30.1\u20131.30.3. 10.1002/cpbi.5", "ArticleIdList": ["10.1002/cpbi.5", "27322403"]}, {"Citation": "Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. Omim.Org: online mendelian inheritance in man (Omim\u00ae), an online catalog of human genes and genetic disorders. Nucleic Acids Res. (2015) 43:D789\u201398. 10.1093/nar/gku1205", "ArticleIdList": ["10.1093/nar/gku1205", "PMC4383985", "25428349"]}, {"Citation": "Zhou Y, Zhang Y, Lian X, Li F, Wang C, Zhu F, et al. . Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res. (2022) 50:D1398\u2013d407. 10.1093/nar/gkab953", "ArticleIdList": ["10.1093/nar/gkab953", "PMC8728281", "34718717"]}, {"Citation": "Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. . David: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. (2022) 50:W216\u201321. 10.1093/nar/gkac194", "ArticleIdList": ["10.1093/nar/gkac194", "PMC9252805", "35325185"]}, {"Citation": "Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. (2020) 8:782\u201392. 10.1016/S2213-8587(20)30238-2", "ArticleIdList": ["10.1016/S2213-8587(20)30238-2", "PMC7367664", "32687793"]}, {"Citation": "Mendelsohn J, Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol. (2006) 33:369\u201385. 10.1053/j.seminoncol.2006.04.003", "ArticleIdList": ["10.1053/j.seminoncol.2006.04.003", "16890793"]}, {"Citation": "Londres HD, Armada JJ, Mart\u00ednez AH, Abdo Cuza AA, S\u00e1nchez YH, Rodr\u00edguez AG, et al. . Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment. Immunotherapy. (2022) 14:521\u201330. 10.2217/imt-2022-0027", "ArticleIdList": ["10.2217/imt-2022-0027", "PMC8936166", "35306855"]}, {"Citation": "Li Y, Pan Y, Cao S, Sasaki K, Wang Y, Niu A, et al. . Podocyte EGFR inhibits autophagy through upregulation of rubicon in type 2 diabetic nephropathy. Diabetes. (2021) 70:562\u201376. 10.2337/db20-0660", "ArticleIdList": ["10.2337/db20-0660", "PMC7881855", "33239448"]}, {"Citation": "Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19. Microb Pathog. (2021) 154:104836. 10.1016/j.micpath.2021.104836", "ArticleIdList": ["10.1016/j.micpath.2021.104836", "PMC7937040", "33691172"]}, {"Citation": "Xu L, Li Y, Yin L, Qi Y, Sun H, Sun P, et al. . miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3. Theranostics. (2018) 8:5593\u2013609. 10.7150/thno.27425", "ArticleIdList": ["10.7150/thno.27425", "PMC6276304", "30555566"]}, {"Citation": "Wang L, Li J, Li D. Losartan reduces myocardial interstitial fibrosis in diabetic cardiomyopathy rats by inhibiting JAK/STAT signaling pathway. Int J Clin Exp Pathol. (2015) 8:466\u201373.", "ArticleIdList": ["PMC4348876", "25755735"]}, {"Citation": "Samidurai A, Roh SK, Prakash M, Durrant D, Salloum FN, Kukreja RC, et al. . STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice. Cardiovasc Res. (2020) 116:2103\u201315. 10.1093/cvr/cvz315", "ArticleIdList": ["10.1093/cvr/cvz315", "PMC8463091", "31738412"]}, {"Citation": "Rathinaswamy MK, Burke JE. Class I phosphoinositide 3-kinase (Pi3k) regulatory subunits and their roles in signaling and disease. Adv Biol Regul. (2020) 75:100657. 10.1016/j.jbior.2019.100657", "ArticleIdList": ["10.1016/j.jbior.2019.100657", "31611073"]}, {"Citation": "Cai W, Zhang J, Yang J, Fan Z, Liu X, Gao W, et al. . MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway. Nutr Metab Cardiovasc Dis. (2019) 29:621\u201332. 10.1016/j.numecd.2019.03.002", "ArticleIdList": ["10.1016/j.numecd.2019.03.002", "31005375"]}, {"Citation": "Yang X, Li X, Lin Q, Xu Q. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA. Gene. (2019) 715:143995. 10.1016/j.gene.2019.143995", "ArticleIdList": ["10.1016/j.gene.2019.143995", "31336140"]}, {"Citation": "Cl\u00e9ment K, Le Stunff C, Meirhaeghe A, Dechartres A, Ferrieres J, Basdevant A, et al. . In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes. Mol Genet Metab. (2009) 96:129\u201332. 10.1016/j.ymgme.2008.11.160", "ArticleIdList": ["10.1016/j.ymgme.2008.11.160", "19097921"]}, {"Citation": "Li J, Zhang K, Bao J, Yang J, Wu C. potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. Int J Med Sci. (2022) 19:213\u201324. 10.7150/ijms.67116", "ArticleIdList": ["10.7150/ijms.67116", "PMC8795796", "35165507"]}, {"Citation": "Li F, Boon ACM, Michelson AP, Foraker RE, Zhan M, Payne PRO. Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19. Sci Rep. (2022) 12:9462. 10.1038/s41598-022-13585-4", "ArticleIdList": ["10.1038/s41598-022-13585-4", "PMC9175532", "35676404"]}, {"Citation": "Gregorio KCR, Laurindo CP, Machado UF. Estrogen and glycemic homeostasis: the fundamental role of nuclear estrogen receptors ESR1/ESR2 in glucose transporter GLUT4 regulation. Cells. (2021) 10:99. 10.3390/cells10010099", "ArticleIdList": ["10.3390/cells10010099", "PMC7827878", "33430527"]}, {"Citation": "Wyler E, M\u00f6sbauer K, Franke V, Diag A, Gottula LT, Arsi\u00e8 R, et al. . Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience. (2021) 24:102151. 10.1016/j.isci.2021.102151", "ArticleIdList": ["10.1016/j.isci.2021.102151", "PMC7866843", "33585804"]}, {"Citation": "Yang X, Zhang Y, Xu W, Deng R, Liu Y, Li F, et al. . Potential role of HSP90 in rat islet function under the condition of high glucose. Acta Diabetol. (2016) 53:621\u20138. 10.1007/s00592-016-0852-2", "ArticleIdList": ["10.1007/s00592-016-0852-2", "26997509"]}, {"Citation": "Vico-Barranco I, Arbulo-Echevarria MM, Serrano-Garc\u00eda I, P\u00e9rez-Linaza A, Miranda-Sayago JM, Miazek A, et al. . A novel, LAT/Lck double deficient T cell subline J.Cam1.7 for combined analysis of early TCR signaling. Cells. (2021) 10:343. 10.3390/cells10020343", "ArticleIdList": ["10.3390/cells10020343", "PMC7915312", "33562083"]}, {"Citation": "Pinchera B, Scotto R, Buonomo AR, Zappulo E, Stagnaro F, Gallicchio A, et al. . Diabetes and COVID-19: the potential role of mTOR. Diabetes Res Clin Pract. (2022) 186:109813. 10.1016/j.diabres.2022.109813", "ArticleIdList": ["10.1016/j.diabres.2022.109813", "PMC8891119", "35248653"]}, {"Citation": "Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. (2012) 149:274\u201393. 10.1016/j.cell.2012.03.017", "ArticleIdList": ["10.1016/j.cell.2012.03.017", "PMC3331679", "22500797"]}, {"Citation": "Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab. (2011) 22:94\u2013102. 10.1016/j.tem.2010.12.003", "ArticleIdList": ["10.1016/j.tem.2010.12.003", "PMC3744367", "21269838"]}, {"Citation": "Fan X, Yin C, Wang J, Yang M, Ma H, Jin G, et al. . Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank. Eur J Epidemiol. (2021) 36:311\u20138. 10.1007/s10654-020-00709-1", "ArticleIdList": ["10.1007/s10654-020-00709-1", "PMC7794621", "33420872"]}, {"Citation": "Khanal P, Duyu T, Patil BM, Dey YN, Pasha I, Wanjari M, et al. . Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19. J Ayurveda Integr Med. (2022) 13:100374. 10.1016/j.jaim.2020.11.004", "ArticleIdList": ["10.1016/j.jaim.2020.11.004", "PMC7687402", "33250601"]}, {"Citation": "Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol. (2018) 15:21\u201332. 10.1038/s41574-018-0096-z", "ArticleIdList": ["10.1038/s41574-018-0096-z", "PMC6624429", "30275460"]}, {"Citation": "Fang L, Tang T, Hu M. Identification of differentially expressed genes in COVID-19 and integrated bioinformatics analysis of signaling pathways. Genet Res. (2021) 2021:2728757. 10.1155/2021/2728757", "ArticleIdList": ["10.1155/2021/2728757", "PMC8710042", "35002537"]}, {"Citation": "Alcover A, Alarc\u00f3n B, Di Bartolo V. Cell biology of T cell receptor expression and regulation. Annu Rev Immunol. (2018) 36:103\u201325. 10.1146/annurev-immunol-042617-053429", "ArticleIdList": ["10.1146/annurev-immunol-042617-053429", "29261409"]}, {"Citation": "Chen YM, Zhu Q, Cai J, Zhao ZJ, Yao BB, Zhou LM, et al. . Upregulation of T cell receptor signaling pathway components in gestational diabetes mellitus patients: joint analysis of mRNA and circRNA expression profiles. Front Endocrinol. (2021) 12:774608. 10.3389/fendo.2021.774608", "ArticleIdList": ["10.3389/fendo.2021.774608", "PMC8763273", "35046894"]}, {"Citation": "Mahmoudi A, Atkin SL, Nikiforov NG, Sahebkar A. Therapeutic role of curcumin in diabetes: an analysis based on bioinformatic findings. Nutrients. (2022) 14:3244. 10.3390/nu14153244", "ArticleIdList": ["10.3390/nu14153244", "PMC9370108", "35956419"]}, {"Citation": "Yang F, Chen R, Li WY, Zhu HY, Chen XX, Hou ZF, et al. . D-limonene is a potential monoterpene to inhibit PI3K/Akt/IKK-?/NF-\u03baB P65 signaling pathway in coronavirus disease 2019 pulmonary fibrosis. Front Med. (2021) 8:591830. 10.3389/fmed.2021.591830", "ArticleIdList": ["10.3389/fmed.2021.591830", "PMC7985179", "33768100"]}, {"Citation": "Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. (2011) 7:146\u201357. 10.2174/157340911795677602", "ArticleIdList": ["10.2174/157340911795677602", "PMC3151162", "21534921"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "2"}, {"Year": "2022", "Month": "11", "Day": "17"}, {"Year": "2022", "Month": "12", "Day": "19", "Hour": "4", "Minute": "16"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36532549", "PMC9755336", "10.3389/fnut.2022.1060095"]}}], "PubmedBookArticle": []}